YUVIA HERRERA ESPINOZA: Open Payments
NPI 1396420279 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 72 payments from 15 companies in 2025. Trend: 2023 $174 · 2024 $1,183 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $185 |
| E.R. Squibb & Sons, L.L.C. | 4 | $141 |
| Teva Pharmaceuticals USA, Inc. | 5 | $112 |
| Indivior Inc. | 3 | $103 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Vertical Pharmaceuticals, LLC | 2 | $42 |
| Corium, LLC | 2 | $34 |
Products named: VRAYLAR, CAPLYTA, COBENFY, SUBLOCADE, INGREZZA, AUSTEDO XR, Auvelity, SPRAVATO.
Industry payments across AZ — which companies pay providers there.
